The CDC recently revised its guidance on the use of face masks. Based on the agency’s new COVID-19 metrics, which rely on local measures of hospital capacity, around 70% of people live in areas where they can go without a mask.
A review of the guidance was the top story in infectious disease last week.
Another top story was about the launch of Moderna’s phase 3 study for its investigational messenger RNA-based RSV vaccine. The company is also testing an mRNA vaccine for influenza and has said that its goal is to create combination vaccines for several respiratory viruses, including